Nota Bene Cancer
Nota Bene Cancer est un bulletin hebdomadaire de veille bibliographique. En libre accès, Nota Bene Cancer permet à ses abonnés de gagner du temps pour se tenir informé de l’actualité scientifique et médicale dans les divers domaines de la recherche sur les cancers.
Rechercher des publications
Pour retrouver les publications signalées par Nota Bene Cancer (archives indexées à partir du n°127 du 1" mars 2012) :
Sommaire du n° 514 du 8 février 2022
Qualité de vie, soins de support (2)
Menée en Corée à partir de données portant sur 3 805 patients atteints d'un cancer, sur 109 patients ayant survécu à la maladie et sur 3 609 témoins en population générale, cette étude analyse l'association entre la qualité de vie et la situation professionnelle
Health-related quality of life among cancer patients and survivors and its relationship with current employment status
Menée en Corée à partir de données portant sur 3 805 patients atteints d'un cancer, sur 109 patients ayant survécu à la maladie et sur 3 609 témoins en population générale, cette étude analyse l'association entre la qualité de vie et la situation professionnelle
Health-related quality of life among cancer patients and survivors and its relationship with current employment status
Kim, Woorim ; Han, Kyu-Tae ; Kim, Seungju
Introduction : Health-related quality of life (HRQoL) is an important end point to measure in cancer patients and survivors. This study investigated whether differences in HRQOL exist between cancer patients, cancer survivors, and the general population, in addition to how employment status interplays in this relationship. Methods : Data were from the 2019 Korea National Health & Nutrition Examination. HRQoL was measured using the HRQoL Instrument with 8 Items (HINT-8) index, which encompasses [...]
Menée en Australie auprès de 142 patients atteints d'un cancer de la prostate, cette étude de cohorte analyse l'intérêt d'un programme en ligne dédié à l'après-cancer et comportant différents types de soins de support pour les patients et leurs aidants
Evaluating a multicomponent survivorship programme for men with prostate cancer in Australia: a single cohort study
Menée en Australie auprès de 142 patients atteints d'un cancer de la prostate, cette étude de cohorte analyse l'intérêt d'un programme en ligne dédié à l'après-cancer et comportant différents types de soins de support pour les patients et leurs aidants
Evaluating a multicomponent survivorship programme for men with prostate cancer in Australia: a single cohort study
Yates, Patsy ; Carter, Rob ; Cockerell, Robyn ; Cowan, Donna ; Dixon, Cyril ; Lal, Anita ; Newton, Robert U ; Hart, Nicolas ; Galvão, Daniel A ; Baguley, Brenton ; Denniston, Nicholas ; Skinner, Tina ; Couper, Jeremy ; Emery, Jon ; Frydenberg, Mark ; Liu, Wei-Hong
Objective :To evaluate the implementation of a multicomponent survivorship programme for men with prostate cancer and their carers. Design A single cohort study, guided by the RE-AIM framework. Setting: Multiple health services in Australia. Participants:Men with prostate cancer and their carers, and health professionals. Intervention : A 12-month telehealth programme that provided centralised and coordinated decision and information support, exercise and nutrition management, specialised [...]
Observation (4)
Menée à partir de données portant sur 23 296 patients atteints d'un cancer et inclus dans des essais cliniques, cette étude analyse le risque d'événements indésirables liés aux différents traitements anticancéreux systémiques (chimiothérapie, immunothérapie, thérapie ciblée), en fonction du sexe
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
Menée à partir de données portant sur 23 296 patients atteints d'un cancer et inclus dans des essais cliniques, cette étude analyse le risque d'événements indésirables liés aux différents traitements anticancéreux systémiques (chimiothérapie, immunothérapie, thérapie ciblée), en fonction du sexe
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
Joseph M. Unger ; Riha Vaidya ; Kathy S. Albain ; Michael LeBlanc ; Lori M. Minasian ; Carolyn C. Gotay ; N. Lynn Henry ; Michael J. Fisch ; Shing M. Lee ; Charles D. Blanke ; Dawn L. Hershman
PURPOSE : Women have more adverse events (AEs) from chemotherapy than men, but few studies have investigated sex differences in immune or targeted therapies. We examined AEs by sex across different treatment domains. METHODS : We analyzed treatment-related AEs by sex in SWOG phase II and III clinical trials conducted between 1980 and 2019, excluding sex-specific cancers. AE codes and grade were categorized using the Common Terminology Criteria for Adverse Events. Symptomatic AEs were defined as [...]
Cette étude présente une projection de la mortalité par cancer dans les pays de l'Union européenne pour l'année 2022, en mettant en avant la mortalité par cancer de l'ovaire
European cancer mortality predictions for the year 2022 with focus on ovarian cancer
Cette étude présente une projection de la mortalité par cancer dans les pays de l'Union européenne pour l'année 2022, en mettant en avant la mortalité par cancer de l'ovaire
European cancer mortality predictions for the year 2022 with focus on ovarian cancer
Dalmartello, M. ; La Vecchia, C. ; Bertuccio, P. ; Boffetta, P. ; Levi, F. ; Negri, E. ; Malvezzi, M.
Background : Cancer mortality rates, though not absolute numbers of deaths, have been decreasing over the last three decades in Europe. Materials and methods : We estimated projections and the number of avoided deaths for total cancer mortality and 10 major cancer sites, between 1989 and 2022, for the European Union (EU), the UK, France, Germany, Italy, Poland and Spain using cancer death certification and population data since 1970 from the World Health Organization and Eurostat. Results : In [...]
Menée en Italie à partir de données portant sur 8 158 patients atteints d'un cancer du pancréas entre 2003 et 2011, cette étude analyse l'association entre une utilisation d'inhibiteurs de l'enzyme de conversion de l'angiotensine après le diagnostic et la survie ainsi que le risque de décès
Angiotensin blockade therapy and survival in pancreatic cancer: a population study
Menée en Italie à partir de données portant sur 8 158 patients atteints d'un cancer du pancréas entre 2003 et 2011, cette étude analyse l'association entre une utilisation d'inhibiteurs de l'enzyme de conversion de l'angiotensine après le diagnostic et la survie ainsi que le risque de décès
Angiotensin blockade therapy and survival in pancreatic cancer: a population study
Keith, Scott W. ; Maio, Vittorio ; Arafat, Hwyda A. ; Alcusky, Matthew ; Karagiannis, Thomas ; Rabinowitz, Carol ; Lavu, Harish ; Louis, Daniel Z.
Background : Pancreatic cancer (PC) is one of the most aggressive and challenging cancer types to effectively treat, ranking as the fourth-leading cause of cancer death in the United States. We investigated if exposures to angiotensin II receptor blockers (ARBs) or angiotensin I converting enzyme (ACE) inhibitors after PC diagnosis are associated with survival. Methods : PC patients were identified by ICD-9 diagnosis and procedure codes among the 3.7 million adults living in the Emilia-Romagna [...]
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Recovery of the breast screening programme following pandemic-related delays: Should we focus on round length or uptake?
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Recovery of the breast screening programme following pandemic-related delays: Should we focus on round length or uptake?
Duffy, Stephen W. ; Hudson, Sue ; Vulkan, Daniel ; Duffy, Thomas E. ; Binysh, Kathie
Objectives: The NHS Breast Screening programme is recovering from the hiatus in screening in 2020 due to the COVID-19 pandemic. Currently, open rather than timed invitations are issued, which leads to lower uptake but more rapid coverage of the eligible population by invitation and therefore closer adherence to a round length of 3 years. We aimed to estimate the likely effect on numbers of cancers detected at incident screens of a range of round lengths and uptake rates. Methods: We assumed [...]
The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation
Duffy, Stephen W. ; Seedat, Farah ; Kearins, Olive ; Press, Mike ; Walton, Jackie ; Myles, Jonathan ; Vulkan, Daniel ; Sharma, Nisha ; Mackie, Anne
Background : Population breast screening services in England were suspended in March 2020 due to the COVID-19 pandemic. Here, we estimate the number of breast cancers whose detection may be delayed because of the suspension, and the potential impact on cancer deaths over 10 years. Methods : We estimated the number and length of screening delays from observed NHS Breast Screening System data. We then estimated additional breast cancer deaths from three routes: asymptomatic tumours progressing to [...]
Disability and remote work during the pandemic with implications for cancer survivors
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Disability and remote work during the pandemic with implications for cancer survivors
Kruse, Douglas ; Park, So Ri ; van der Meulen Rodgers, Yana ; Schur, Lisa
Purpose : This article examines the extent to which employees worked from home because of the pandemic, focusing on differentials between people with and without disabilities with implications for cancer survivors. Methods : We use data on COVID-19 from the Current Population Survey over the May 2020 to June 2021 period. We present descriptive statistics and the results from regression and decomposition analysis. Results : While workers with disabilities were more likely than those without [...]
Parallel Evolution and Differences in Seroprevalence of SARS-CoV-2 Antibody Between Cancer Patients and Health Care Workers in a Tertiary Cancer Ce...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Parallel Evolution and Differences in Seroprevalence of SARS-CoV-2 Antibody Between Cancer Patients and Health Care Workers in a Tertiary Cancer Center During First and Second Wave of COVID-19 Pandemic: canSEROcov-II Cross Sectional Study
Ladoire, Sylvain ; Rederstorff, Emilie ; Goussot, Vincent ; Parnalland, Sophie ; Briot, Nathalie ; Ballot, Elise ; Truntzer, Caroline ; Ayati, Siavoshe ; Bengrine-Lefevre, Leila ; Bremaud, Nathalie ; Coudert, Bruno ; Desmoulins, Isabelle ; Favier, Laure ; Fraisse, Cléa ; Fumet, Jean-David ; Hennequin, Audrey ; Hervieu, Alice ; Ilie, Silvia ; Kaderbhai, Coureche ; Lagrange, Aurélie ; Martin, Nils ; Mazilu, Irina ; Mayeur, Didier ; Palmier, Rémi ; Simonet-Lamm, Anne-Laure ; Vincent, Julie ; Zanetta, Sylvie ; Arnould, Laurent ; Coutant, Charles ; Bertaut, Aurélie ; Ghiringhelli, François
Background : Patients with cancer are a population at high risk of severe infection from SARS-CoV-2. Cancer patients regularly attend specialized healthcare centres for management and treatment, where they are in contact with healthcare workers (HCWs). Numerous recommendations target both patients with cancer and HCWs, to minimize the spread of SARS-CoV-2 during these interactions. Objective : To investigate the parallel evolution of the COVID-19 epidemic in these 2 populations over time, we [...]
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study
Mair, Maximilian J. ; Berger, Julia M. ; Mitterer, Manfred ; Gansterer, Margaretha ; Bathke, Arne C. ; Trutschnig, Wolfgang ; Berghoff, Anna S. ; Perkmann, Thomas ; Haslacher, Helmuth ; Lamm, Wolfgang W. ; Raderer, Markus ; Tobudic, Selma ; Fuereder, Thorsten ; Buratti, Thomas ; Fong, Dominic ; Preusser, Matthias
Background : Due to potentially immune-escaping virus variants and waning immunity, a third SARS-CoV-2 vaccination dose is increasingly recommended. However, data in patients with cancer are limited. Patients and methods : We measured anti-SARS-CoV-2 spike protein antibody levels after the third vaccination dose in 439 patients with cancer and 41 health care workers (HCW) at an academic center in Austria and a rural community hospital in Italy. Adverse events were retrieved from questionnaires. [...]
Impact of the COVID-19 pandemic on cancer patients and psycho-oncology providers: Perspectives, observations, and experiences of the American Psych...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Impact of the COVID-19 pandemic on cancer patients and psycho-oncology providers: Perspectives, observations, and experiences of the American Psychosocial Oncology Society (APOS) membership
McAndrew, Natalie S. ; Strong, Yukino ; Morris, Keayra J. ; Sannes, Timothy S. ; Pirl, William F. ; Cole, Steve ; Mohanraj, Lathika ; Knight, Jennifer M.
Objective: To understand: (1) psycho-oncology providersX2019; perspectives on and observations of the psychological responses of their cancer patients during the pandemic, and (2) psycho-oncology providersX2019; own experiences delivering care. Methods: In this concurrent mixed methods study, a survey was distributed to psychosocial providers who were members of the American Psychosocial Oncology Society (APOS). Survey respondents were invited to participate in a one-on-one audio-recorded [...]
The benefits and consequences of the COVID-19 pandemic for patients diagnosed with cancer and their family caregivers
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
The benefits and consequences of the COVID-19 pandemic for patients diagnosed with cancer and their family caregivers
Steel, Jennifer L. ; Amin, Aarshati ; Peyser, Tristen ; Olejniczak, Donna ; Antoni, Michael ; Carney, Maureen ; Tillman, Emily ; Hecht, Carol Lynn ; Pandya, Niva ; Miceli, Jessica ; Reyes, Vincent ; Nilsen, Marci ; Johnson, Jonas ; Kiefer, Gauri ; Pappu, Bhanu ; Zandberg, Dan P. ; Geller, David A.
Background : The objectives of this study were to examine benefits and consequences of the COVID-19 pandemic for patients diagnosed with cancer and their family caregivers. Methods : A 23-item questionnaire assessing COVID-19-related issues, the Patient Health Questionnaire-2, Generalized Anxiety Disorder-2, Pittsburgh Sleep Quality Index, and the Perceived Stress Scale (PSS)-4 were administered to patients diagnosed with cancer and their family caregivers. Results : Of the 161 patients and 78 [...]
Variable Impact of the COVID-19 Pandemic on U.S. Radiation Oncology Practices
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Variable Impact of the COVID-19 Pandemic on U.S. Radiation Oncology Practices
Wakefield, Daniel V. ; Eichler, Thomas ; Wilson, Emily ; Gardner, Liz ; Collet-Lipscomb, Casey ; Schwartz, David L.
Early in the pandemic, the American Society for Radiation Oncology (ASTRO) surveyed physician leaders at U.S. radiation oncology practices to understand how the field was responding to the outbreak of COVID-19. Surveys were repeated at multiple points during the pandemic, with a response rate of 43% in April 2020 and 23% in January 2021. To our knowledge, this is the only longitudinal COVID-19 practice survey in oncology in the U.S. The surveys indicate that patient access to essential [...]
A definitive prognostication system for patients with thoracic malignancies diagnosed with COVID-19: an update from the TERAVOLT registry
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
A definitive prognostication system for patients with thoracic malignancies diagnosed with COVID-19: an update from the TERAVOLT registry
Whisenant, Jennifer G. ; Baena, Javier ; Cortellini, Alessio ; Huang, Li-Ching ; Lo Russo, Giuseppe ; Porcu, Luca ; Wong, Selina K. ; Bestvina, Christine M. ; Hellmann, Matthew D. ; Roca, Elisa ; Rizvi, Hira ; Monnet, Isabelle ; Boudjemaa, Amel ; Rogado, Jacobo ; Pasello, Giulia ; Leighl, Natasha B. ; Arrieta, Oscar ; Aujayeb, Avinash ; Batra, Ullas ; Azzam, Ahmed Y. ; Unk, Mojca ; Azab, Mohammed A. ; Zhumagaliyeva, Ardak N. ; Gomez-Martin, Carlos ; Blaquier, Juan B. ; Geraedts, Erica ; Mountzios, Giannis ; Serrano-Montero, Gloria ; Reinmuth, Niels ; Coate, Linda ; Marmarelis, Melina ; Presley, Carolyn J. ; Hirsch, Fred R. ; Garrido, Pilar ; Khan, Hina ; Baggi, Alice ; Mascaux, Celine ; Halmos, Balazs ; Ceresoli, Giovanni L. ; Fidler, Mary J. ; Scotti, Vieri ; Métivier, Anne-Cécile ; Falchero, Lionel ; Felip, Enriqueta ; Genova, Carlo ; Mazières, Julien ; Tapan, Umit ; Brahmer, Julie ; Bria, Emilio ; Puri, Sonam ; Popat, Sanjay ; Reckamp, Karen L. ; Morgillo, Floriana ; Nadal, Ernest ; Mazzoni, Francesca ; Agustoni, Francesco ; Bar, Jair ; Grosso, Federica ; Avrillon, Virginie ; Patel, Jyoti D. ; Gomes, Fabio ; Ibrahim, Ehab ; Trama, Annalisa ; Bettini, Anna C. ; Barlesi, Fabrice ; Dingemans, Anne-Marie ; Wakelee, Heather ; Peters, Solange ; Horn, Leora ; Garassino, Marina Chiara ; Torri, Valter
Background: Patients with thoracic malignancies are at increased risk for mortality from Coronavirus disease 2019 (COVID-19) and large number of intertwined prognostic variables have been identified so far. Methods: Capitalizing data from the TERAVOLT registry, a global study created with the aim of describing the impact of COVID-19 in patients with thoracic malignancies, we used a clustering approach, a fast-backward step-down selection procedure and a tree-based model to screen and optimize a [...]
The impact of COVID-19 on cancer care of outpatients with low socioeconomic status
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
The impact of COVID-19 on cancer care of outpatients with low socioeconomic status
Zeilinger, Elisabeth L. ; Lubowitzki, Simone ; Unseld, Matthias ; Schneckenreiter, Carmen ; Heindl, Daniel ; Staber, Philipp B. ; Raderer, Markus ; Valent, Peter ; Zöchbauer-Müller, Sabine ; Bartsch, Rupert ; Prager, Gerald ; Jaeger, Ulrich ; Gaiger, Alexander
Patients with low socioeconomic status are among the most underserved groups of people regarding cancer care. Analyzing the impact of the COVID-19 pandemic on health care disparities and calling attention to inequalities in cancer care is crucial to justify and initiate adequate countermeasures. We aimed to determine whether the COVID-19 pandemic aggravated health care disparities of cancer outpatients related to their socioeconomic status and analyzed patient data of the largest university [...]
Approches psycho-sociales (3)
Menée aux Etats-Unis auprès de 76 couples dont l'un des partenaires est atteint d'un cancer de stade avancé (cancer du poumon de stade III/V ou tumeur cérébrale de grade III/IV), cette étude analyse la présence de difficultés financières et évalue l'impact de ces difficultés sur les symptômes et la qualité de vie
Financial distress and its associated burden in couples coping with an advanced cancer
Menée aux Etats-Unis auprès de 76 couples dont l'un des partenaires est atteint d'un cancer de stade avancé (cancer du poumon de stade III/V ou tumeur cérébrale de grade III/IV), cette étude analyse la présence de difficultés financières et évalue l'impact de ces difficultés sur les symptômes et la qualité de vie
Financial distress and its associated burden in couples coping with an advanced cancer
Kroll, Juliet L. ; Kim, Seokhun ; Cho, Dalnim ; Weathers, Shiao-Pei ; Chen, Aileen B. ; Smith, Grace ; Bruera, Eduardo ; Milbury, Kathrin
Purpose : In efforts to understand financial distress (FD) associated with advanced cancer care from the perspective of both patients with incurable disease and their spousal caregivers, we assessed FD in both members of the couple, identified symptom and quality of life (QOL) correlates, and examined the potential role of illness communication. Methods : Patients undergoing treatment for stage III/IV lung cancer or a grade III/IV primary brain tumor and their spousal caregivers (n = 76 dyads) [...]
Menée auprès de 430 patients atteints d'un cancer et ayant reçu une greffe de cellules souches hématopoïétiques, cette étude identifie les facteurs associés à la croissance posttraumatique
Predictors of Posttraumatic Growth Among Hematopoietic Cell Transplant Recipients
Menée auprès de 430 patients atteints d'un cancer et ayant reçu une greffe de cellules souches hématopoïétiques, cette étude identifie les facteurs associés à la croissance posttraumatique
Predictors of Posttraumatic Growth Among Hematopoietic Cell Transplant Recipients
Schwartz, Jessica R. ; Thomas, Emily B. K. ; Juckett, Mark B. ; Costanzo, Erin S.
Objective : Prior research has shown that cancer survivors often report positive psychological changes from the experience of cancer, or posttraumatic growth (PTG). However, few studies have focused on PTG in cancer patients recovering from hematopoietic cell transplantation (HCT). The present study measured PTG at specific milestones during the year following HCT and investigated psychosocial and treatment-related factors that may hinder or facilitate PTG. Methods : Participants (N = 430) [...]
Menée à partir de données portant sur 519 patientes atteintes d'un cancer du sein et sur 338 témoins, cette étude analyse l'association entre la présence d'une inflammation et des difficultés dans l'attention et la rapidité de traitement des informations, avant et après la chimiothérapie
Inflammation, Attention, and Processing Speed in Patients with Breast Cancer before and after Chemotherapy
Menée à partir de données portant sur 519 patientes atteintes d'un cancer du sein et sur 338 témoins, cette étude analyse l'association entre la présence d'une inflammation et des difficultés dans l'attention et la rapidité de traitement des informations, avant et après la chimiothérapie
Inflammation, Attention, and Processing Speed in Patients with Breast Cancer before and after Chemotherapy
Belcher, Elizabeth K ; Culakova, Eva ; Gilmore, Nikesha J ; Hardy, Sara J ; Kleckner, Amber S ; Kleckner, Ian R ; Lei, Lianlian ; Heckler, Charles ; Sohn, Michael B ; Thompson, Bryan D ; Lotta, Louis T, Jr ; Werner, Zachary A ; Geer, Jodi ; Hopkins, Judith O ; Corso, Steven W ; Rich, David Q ; van Wijngaarden, Edwin ; Janelsins, Michelle C
Background : Inflammation may contribute to cognitive difficulties in patients with breast cancer. We tested two hypotheses: inflammation is elevated in patients versus control subjects, and inflammation is associated with worse attention and processing speed over the course of chemotherapy. Methods : Serum cytokines (IL-4, 6, 8, 10; TNF- [...]
Analyses économiques et systèmes de soins (2)
Menée aux Etats-Unis par questionnaire auprès de 1 576 patients atteints d'un cancer, cette étude prospective analyse l'association entre une hospitalisation non programmée, la durée du séjour, les symptômes et la satisfaction vis-à-vis de la qualité et de la coordination des soins reçus
Associations of patient-reported care satisfaction with symptom burden and healthcare use in hospitalized patients with cancer
Menée aux Etats-Unis par questionnaire auprès de 1 576 patients atteints d'un cancer, cette étude prospective analyse l'association entre une hospitalisation non programmée, la durée du séjour, les symptômes et la satisfaction vis-à-vis de la qualité et de la coordination des soins reçus
Associations of patient-reported care satisfaction with symptom burden and healthcare use in hospitalized patients with cancer
Qian, Carolyn L. ; Kaslow-Zieve, Emilia R. ; Azoba, Chinenye C. ; Horick, Nora ; Wang, Irene ; Van Seventer, Emily ; Newcomb, Richard ; Cashavelly, Barbara J. ; Jackson, Vicki A. ; Ryan, David P. ; Greer, Joseph A. ; El-Jawahri, Areej ; Temel, Jennifer S. ; Nipp, Ryan D.
Background : Hospitalized patients with cancer often experience a high symptom burden, which may impact care satisfaction and healthcare utilization. Methods : We prospectively enrolled patients with cancer and unplanned hospitalizations from September 2014 to April 2017. Upon admission, we assessed patients’ care satisfaction (FAMCARE items: satisfaction with care coordination and speed with which symptoms are treated) and physical (Edmonton Symptom Assessment System [ESAS]) and psychological [...]
Menée dans un contexte américain, cette étude compare le rapport coût-efficacité de deux stratégies thérapeutiques pour les patients atteints d'un cancer du rectum de stade localement avancé et résécable, l'une comportant une radiothérapie de courte durée et une thérapie néoadjuvante totale (traitement de type SCRT-TNT) suivie d'une excision mésorectale totale, et l'autre comportant une chimioradiothérapie conventionnelle de longue durée (traitement de type LCCRT) suivie d'une excision mésorectale totale et d'une chimiothérapie adjuvante
Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer
Menée dans un contexte américain, cette étude compare le rapport coût-efficacité de deux stratégies thérapeutiques pour les patients atteints d'un cancer du rectum de stade localement avancé et résécable, l'une comportant une radiothérapie de courte durée et une thérapie néoadjuvante totale (traitement de type SCRT-TNT) suivie d'une excision mésorectale totale, et l'autre comportant une chimioradiothérapie conventionnelle de longue durée (traitement de type LCCRT) suivie d'une excision mésorectale totale et d'une chimiothérapie adjuvante
Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer
Chin, Re-I ; Otegbeye, Ebunoluwa E. ; Kang, Kylie H. ; Chang, Su-Hsin ; McHenry, Scott ; Roy, Amit ; Chapman, William C., Jr ; Henke, Lauren E. ; Badiyan, Shahed N. ; Pedersen, Katrina ; Tan, Benjamin R. ; Glasgow, Sean C. ; Mutch, Matthew G. ; Samson, Pamela P. ; Kim, Hyun
Importance : Short-course radiotherapy and total neoadjuvant therapy (SCRT-TNT) followed by total mesorectal excision (TME) has emerged as a new treatment paradigm for patients with locally advanced rectal adenocarcinoma. However, the economic implication of this treatment strategy has not been compared with that of conventional long-course chemoradiotherapy (LCCRT) followed by TME with adjuvant chemotherapy. Objective : To perform a cost-effectiveness analysis of SCRT-TNT vs LCCRT in [...]
Soins palliatifs (1)
Menée en Asie (Japon, Corée, Taïwan) à partir de données portant sur 1 530 patients atteints d'un cancer en phase terminale, cette étude analyse l'association entre le niveau d'hydratation artificielle et la qualité du décès
Association between the amount of artificial hydration and quality of dying among terminally ill patients with cancer: The East Asian Collaborative...
Menée en Asie (Japon, Corée, Taïwan) à partir de données portant sur 1 530 patients atteints d'un cancer en phase terminale, cette étude analyse l'association entre le niveau d'hydratation artificielle et la qualité du décès
Association between the amount of artificial hydration and quality of dying among terminally ill patients with cancer: The East Asian Collaborative Cross-Cultural Study to Elucidate the Dying Process
Wu, Chien-Yi ; Chen, Ping-Jen ; Cheng, Shao-Yi ; Suh, Sang-Yeon ; Huang, Hsien-Liang ; Lin, Wen-Yuan ; Hiratsuka, Yusuke ; Kim, Sun-Hyun ; Yamaguchi, Takashi ; Morita, Tatsuya ; Tsuneto, Satoru ; Mori, Masanori ; EASED Investigators
Background : Artificial hydration (AH) is a challenging issue in terminally ill patients with cancer, because it influences patients' symptoms control, quality of life, and quality of dying (QOD). To date, it is not clear how much AH supply is proper for imminently dying patients. This study aimed to investigate the association between the amount of AH and QOD. Methods : This study is part of the East Asian Collaborative Cross-Cultural Study to Elucidate the Dying Process (EASED) conducted in [...]